Results 171 to 180 of about 1,602 (208)
Some of the next articles are maybe not open access.
Drug intelligence & clinical pharmacy, 1988
Carbocysteine is prescribed for conditions characterized by the accumulation of excessive mucus. Although often described as a mucolytic, its function is probably that of mucoregulation, which results in physical changes in accumulated secretions that are favorable in terms of clearance.
openaire +1 more source
Carbocysteine is prescribed for conditions characterized by the accumulation of excessive mucus. Although often described as a mucolytic, its function is probably that of mucoregulation, which results in physical changes in accumulated secretions that are favorable in terms of clearance.
openaire +1 more source
[Carbocysteine in the treatment of recurrent bronchitis in infants].
Ceskoslovenska pediatrie, 1992In a group of 51 children aged 6-24 months the therapeutic effectiveness of the mucolytic preparation carbocysteine was tested and compared with the effect of Ipeca syrup. The effect was evaluated by means of a point score comprising changes of the clinical picture of the disease and the use of other laboratory examinations.
P, Bánovcin +4 more
openaire +1 more source
Treatment of carbocysteine wastewater by bipolar membrane electrodialysis: From lab-to pilot-scale
Journal of Membrane Science, 2023Zheng Peng +5 more
semanticscholar +1 more source
[Fixed carbocysteine drug eruption. Clinical case in primary care].
Semergen, 2023A. M. López Carabaño +3 more
semanticscholar +1 more source
Evaluation of the activity of the carbocysteine-sobrerol combination on mucus spinnability.
International journal of clinical pharmacology research, 1988Among the rheological properties of bronchial mucus, "spinnability", i.e. the ability to form threads under the effect of traction, should be regarded as the most closely related to the mucociliary transport function. In the present study the "spinnability" parameter was included in the functional tests aimed at evaluating the efficacy of the ...
DISTEFANO SM +5 more
openaire +2 more sources
A comparative bioavailability study of a generic capsule formulation containing carbocysteine.
Die Pharmazie, 2006The bioequivalence of two carbocysteine capsulae preparations was assessed in 18 healthy volunteers who received a single 750 mg dose of each carbocysteine formulation, and a new sensitive method for the quantification of carbocysteine in human plasma was developed.
D, Jovanović +5 more
openaire +1 more source
European cytokine network, 2003
Carbocysteine lysine salt monohydrate (SCMC-Lys) is a well-known mucoactive drug whose therapeutic efficacy is commonly related to the ability of SCMC-Lys to replace fucomucins by sialomucins. The aim of this study was to determine if SCMC-Lys could exert an anti-oxidant action by scavenging reactive oxygen intermediates (ROIs).
Brandolini, Laura +9 more
openaire +2 more sources
Carbocysteine lysine salt monohydrate (SCMC-Lys) is a well-known mucoactive drug whose therapeutic efficacy is commonly related to the ability of SCMC-Lys to replace fucomucins by sialomucins. The aim of this study was to determine if SCMC-Lys could exert an anti-oxidant action by scavenging reactive oxygen intermediates (ROIs).
Brandolini, Laura +9 more
openaire +2 more sources
Bioavailability of two formulations of carbocysteine in healthy volunteers
European Journal of Pharmacology, 1990A. Sabo, V. Jakovljevi, B. Bani
openaire +1 more source